1. Asano, S., Masako, T., and Takaku, F., 1991, Beneficial effect of recombinant human granulocyte stimulating factor in marrow transplanted patients: Results of multicenter phase II studies, Transplant. Proc. 23:1701.
2. Ash, R. C., Casper, J. T., Chitambar, C. C., Hansen, R., Bunin, N., Truitt, R. L., Lawton, C., Murray, K., Hunter, J., Baxter-Lowe, L. A., Grottschalli, J. L., Oldham, K., Anderson, T., Camitta, B., and Menitove, J., 1990, Successful allogeneic transplantation of T cell depleted bone marrow from closely HLA matched unrelated donors, N. Engl. J. Med. 322:485.
3. Atkinson, K., Biggs, J. C., Britton, K., Short, R., Mrongoverus, R., Concannon, A., and Dodds, A., 1984, Oral administration of cyclosporin A for recipients of allogeneic marrow transplants: Implications of clinical gut dysfunction, Br. J.J. Haematol 56:223.
4. Bacigalupo, A., van Lint, M. T., Frassoni, F., Podesta, M., Veneziano, G., Avanzi, G., Vitale, V, and Marmont, A. M., 1983, High dose bolus methylprednisolone for the treatment of acute graft versus host disease, Blut 46:125.
5. Bacigalupo, A., Maiolino, A., van Lint, M. T., Occhini, D., Gualandi, F., Clavio, M., Lamparelli, T., Tong, J., and Marmont, A. M., 1990, Cyclosporin A and chronic graft versus host disease, Bone Marrow Transplant. 6:341.